460 related items for PubMed ID: 12107224
1. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP.
J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
[Abstract] [Full Text] [Related]
2. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.
Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB.
J Clin Endocrinol Metab; 2000 Mar; 85(3):1114-20. PubMed ID: 10720048
[Abstract] [Full Text] [Related]
3. A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.
Laue L, Merke DP, Jones JV, Barnes KM, Hill S, Cutler GB.
J Clin Endocrinol Metab; 1996 Oct; 81(10):3535-9. PubMed ID: 8855797
[Abstract] [Full Text] [Related]
4. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia.
Charmandari E, Johnston A, Honour JW, Brook CG, Hindmarsh PC.
J Pediatr Endocrinol Metab; 2002 Apr; 15(4):435-9. PubMed ID: 12008691
[Abstract] [Full Text] [Related]
5. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
[Abstract] [Full Text] [Related]
6. New approaches to the treatment of congenital adrenal hyperplasia.
Merke DP, Cutler GB.
JAMA; 1997 Apr 02; 277(13):1073-6. PubMed ID: 9091697
[No Abstract] [Full Text] [Related]
7. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Clin Endocrinol Metab; 2002 May 02; 87(5):2238-44. PubMed ID: 11994370
[Abstract] [Full Text] [Related]
8. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.
Charmandari E, Hindmarsh PC, Johnston A, Brook CG.
J Clin Endocrinol Metab; 2001 Jun 02; 86(6):2701-8. PubMed ID: 11397874
[Abstract] [Full Text] [Related]
9. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I, Cutler GB.
Clin Endocrinol (Oxf); 1999 Sep 02; 51(3):285-91. PubMed ID: 10469007
[Abstract] [Full Text] [Related]
10. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Charmandari E, Johnston A, Brook CG, Hindmarsh PC.
J Endocrinol; 2001 Apr 02; 169(1):65-70. PubMed ID: 11250647
[Abstract] [Full Text] [Related]
11. Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia.
Merke DP, Cho D, Calis KA, Keil MF, Chrousos GP.
J Clin Endocrinol Metab; 2001 Jan 02; 86(1):441-5. PubMed ID: 11232038
[Abstract] [Full Text] [Related]
12. Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity.
Nordenström A, Marcus C, Axelson M, Wedell A, Ritzén EM.
J Clin Endocrinol Metab; 1999 Apr 02; 84(4):1210-3. PubMed ID: 10199755
[Abstract] [Full Text] [Related]
13. Effect of ethosuximide on cortisol metabolism in the treatment of congenital adrenal hyperplasia.
Yau M, Rao N, Nimkarn S, Vogiatzi M.
J Pediatr Endocrinol Metab; 2014 May 02; 27(5-6):549-54. PubMed ID: 24468605
[Abstract] [Full Text] [Related]
14. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
Hochberg Z, Benderly A, Kahana L, Zadik Z.
J Clin Endocrinol Metab; 1986 Jul 02; 63(1):36-40. PubMed ID: 3011843
[Abstract] [Full Text] [Related]
15. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J, Aldridge S, Thomas M, Cheetham T.
J Pediatr Endocrinol Metab; 2018 Sep 25; 31(9):1019-1022. PubMed ID: 30173205
[Abstract] [Full Text] [Related]
16. Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Gröschl M, Rauh M, Dörr HG.
J Clin Endocrinol Metab; 2002 Mar 25; 87(3):1200-4. PubMed ID: 11889188
[Abstract] [Full Text] [Related]
17. [Aggravation of salt loss due to hydrocortisone in the first days of treatment of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency].
Bey-Omar F, Feit JP, Forest MG, David M.
Pediatrie; 1983 Mar 25; 38(2):77-86. PubMed ID: 6622141
[Abstract] [Full Text] [Related]
18. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 25; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
19. Sexual dimorphism in the synchrony of joint growth hormone and cortisol dynamics in children with classic 21-hydroxylase deficiency.
Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Pediatr Endocrinol Metab; 2003 Jan 25; 16(8):1119-30. PubMed ID: 14594172
[Abstract] [Full Text] [Related]
20. Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment.
Hero M, Jänne OA, Näntö-Salonen K, Dunkel L, Raivio T.
J Clin Endocrinol Metab; 2005 Sep 25; 90(9):5141-5. PubMed ID: 15985486
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
